Skip to content

The Application and Safety Evaluation of Home-grown Robotic Surgery System in Pancreatic Surgery

The Application and Safety Evaluation of Intraperitoneal Endoscopic Surgical System (MP2000) in Pancreatic Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128588
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign or malignant pancreatic tumor requiring surgical treatment.

Interventions

Sponsors

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.With indication of pancreatic tumor surgery; 2.Tolerance to laparoscopic surgery; 3.Willing to coordinate and finish the examinations and follow-ups. 4.Willing to participate the clinical trail with consent signature of patients themselves or their guardians. 5. Age 18-75 years old.

Exclusion criteria

Exclusion criteria: 1. Those needing emergency surgery or who can't tolerate anesthesia for laparoscopy; 2. Those with other underlying health conditions that the researcher thinks make them unsuitable for this study; 3. Those who have had other abdominal surgeries and are deemed unsuitable for this study by the researcher; 4. Those with severe systemic diseases deemed unfit for surgery by the researcher; 5. Those with a history of epilepsy, mental illness, or cognitive impairment; 6. People with severe allergies or suspected/confirmed alcohol or drug addiction; 7. Those who have other surgical contraindications; 8. People currently participating in other interventional clinical trials (except in vitro diagnostic tests); 9. Anyone the researcher thinks shouldn’t participate (like if the person doesn’t want to follow the study plan, has unrealistic expectations, or obvious emotional issues).

Design outcomes

Primary

MeasureTime frame
Conversion to open surgery;bloodloss;surgical duration;Transfusion;

Countries

China

Contacts

Public ContactJiabin Jin

Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

jjb11501@rjh.com.cn+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026